Desq Long
Sign in

Company

Xenon Pharmaceuticals Inc.

XENE · CIK 0001582313

SEC FORM 4
$41,923.60

Xenon Pharmaceuticals Inc. (XENE)

Acquisition (code M) of 5,144 shares at $8.15 per share.

Reporting Person Svoronos Dawn · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382412 · filed 2026-09-03 · View filing →

SEC FORM 4
$383,145.37

Xenon Pharmaceuticals Inc. (XENE)

Sale of 6,368 shares at $60.1673 per share.

Reporting Person KENNEY CHRISTOPHER JOHN · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001193125-26-377309 · filed 2026-08-31 · View filing →

SEC FORM 4
$42,683.62

Xenon Pharmaceuticals Inc. (XENE)

Sale of 700 shares at $60.9766 per share.

Reporting Person KENNEY CHRISTOPHER JOHN · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001193125-26-377309 · filed 2026-08-31 · View filing →

SEC FORM 4
$640,550.00

Xenon Pharmaceuticals Inc. (XENE)

Sale of 10,000 shares at $64.055 per share.

Reporting Person GANNON STEVEN · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001193125-26-349351 · filed 2026-08-13 · View filing →